Aminov Erez insider trades
Aminov Erez has filed 14 Form 4s with the SEC that we hold, for Mira Pharmaceuticals, INC. (MIRA) (Chief Executive Officer, Director) and Telomir Pharmaceuticals, Inc. (TELO) (CEO and Chairman, Director). Across all of them we count 8 purchases worth $8.2K and 5 sales worth $1.4M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($1.3M). The largest single trade was a sale of 613,595 shares of Mira Pharmaceuticals, INC. worth $1.3M, dated 2025-10-16. The first filing on our record is dated 2023-08-21 and the latest 2026-05-22.
Mira Pharmaceuticals, INC. (MIRA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-05-21 | P, purchase reported on Form 4 | 600 | $522 | 2024-05-22 |
| 2024-05-21 | P, purchase reported on Form 4 | 800 | $808 | 2024-05-22 |
| 2024-05-21 | P, purchase reported on Form 4 | 2,000 | $2.0K | 2024-05-22 |
| 2024-05-21 | P, purchase reported on Form 4 | 500 | $510 | 2024-05-22 |
| 2024-05-21 | P, purchase reported on Form 4 | 1,000 | $1.0K | 2024-05-22 |
| 2024-05-21 | P, purchase reported on Form 4 | 800 | $776 | 2024-05-22 |
| 2024-05-21 | P, purchase reported on Form 4 | 2,000 | $1.7K | 2024-05-22 |
| 2024-05-21 | P, purchase reported on Form 4 | 1,000 | $850 | 2024-05-22 |
| 2024-11-19 | S, sale reported on Form 4 | 55,410 | $77.0K | 2024-11-27 |
| 2024-11-20 | S, sale reported on Form 4 | 44,590 | $56.6K | 2024-11-27 |
| 2025-10-16 | S, sale reported on Form 4 | 613,595 | $1.3M | 2026-02-17 |
Telomir Pharmaceuticals, Inc. (TELO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-08-19 | S, sale reported on Form 4 | 200 | $1.2K | 2025-02-04 |
| 2024-08-19 | S, sale reported on Form 4 | 200 | $1.2K | 2025-02-04 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1986112) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms